Aurinia Pharmaceuticals
AUPH
AUPH
187 hedge funds and large institutions have $416M invested in Aurinia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 53 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
-10
Holders Change %
-5.08%
% of All Funds
3.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
56
Reduced
53
Closed
31
Calls
$23.8M
Puts
$12.7M
Net Calls
+$11.1M
Net Calls Change
+$199K
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$42.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$20.7M |
| 3 |
AC
Armistice Capital
New York
|
$5.44M |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
$4.31M |
| 5 |
Two Sigma Investments
New York
|
$3.94M |
